Skip to content

One in eight European children with HIV experienced failure of three drug classes within five years

Young adults who were infected at birth: the complexities of lifelong HIV are increasingly apparent

Cotrimoxazole prophylaxis for HIV-positive infants aids growth, reduces anaemia

Breastfeeding infants with HIV may develop drug resistance from ARVs in breast milk

Watch for malnutrition risk in children with HIV after starting ART

Optimising infant HIV treatment in resource-limited settings: when can nevirapine be used?

Six months of nevirapine prophylaxis for breastfeeding infants reduces transmission by 76% if mother not on ART

NNRTIS and PIs equal in children, trials shows, but PIs may delay need for switch to second-line

High bilirubin levels may be more frequent in adolescents taking atazanavir